The complexity of multiple sclerosis (MS) treatment means that doctors and decision-makers
need the best available evidence to make the best decisions for patient care. Randomized …

Multiple sclerosis (MS) is a common, disabling, putatively autoimmune neurological disease
with worldwide distribution. It typically begins as a relapsing disorder that later evolves to a …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

Objective Many JC virus antibody‐positive relapsing–remitting multiple sclerosis (RRMS)
patients who are stable on natalizumab switch to other therapies to avoid progressive …

Pregnancy and Family Planning in Multiple Sclerosis : CONTINUUM: Lifelong Learning in
Neurology Account Register Activate Subscription Help Subscribe American Academy of …

Background: Natalizumab (NTZ) is sometimes discontinued in patients with multiple
sclerosis, mainly due to concerns about the risk of progressive multifocal …

Importance Autologous hematopoietic stem cell transplant (AHSCT) is available for
treatment of highly active multiple sclerosis (MS). Objective To compare the effectiveness of …

Objective Oral immunotherapies have become a standard treatment in relapsing-remitting
multiple sclerosis. Direct comparison of their effect on relapse and disability is needed …

Monitoring, Switching, and Stopping Multiple Sclerosis Disea... : CONTINUUM: Lifelong
Learning in Neurology Account Register Activate Subscription Help Subscribe American …

Importance Natalizumab cessation is associated with a risk of rebound disease activity. It is
important to identify the optimal switch disease-modifying therapy strategy after natalizumab …